%D9%81%D9%84%D9%8A%D9%83%D8%A7%D9%8A%D9%86%D9%8A%D8%AF%D9%81%D9%84%DA%A9%D8%A7%DB%8C%D9%86%DB%8C%D8%AFFlecainidFlecainideFlecainida%D9%81%D9%84%DA%A9%D8%A7%DB%8C%D9%86%DB%8C%D8%AFFl%C3%A9ca%C3%AFnideFlecainide%E3%83%95%E3%83%AC%E3%82%AB%E3%82%A4%E3%83%8B%E3%83%89FlekainidFlecainidaFlekainidFlekainid%D0%A4%D0%BB%D0%B5%D0%BA%D0%B0%D1%97%D0%BD%D1%96%D0%B4FlecainideQ421381
about
P3781
probucolclarithromycinpimozideazithromycindroperidol(RS)-methadoneerythromycinhaloperidoldofetilideibutilidechlorpromazineanagrelidedronedarone(RS)-citalopramondansetronamiodaronequinidinesotalolcocainepentamidineprocainamideterfenadinesevofluranesulpiridechloroquineastemizoleescitalopramdomperidonemoxifloxacindisopyramidecisapridebepridilthioridazinemesoridazinearsenic trioxideHalofantrinesparfloxacin
P769
Flecainide-associated bradycardia-dependent torsade de pointes: another potential mechanism of proarrhythmia.Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.Single oral flecainide dose to unmask type 1 Brugada syndrome electrocardiographic pattern.Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytesA chemical genomics approach to identification of interactions between bioactive molecules and alternative reading frame proteins.Flecainide reduces Ca(2+) spark and wave frequency via inhibition of the sarcolemmal sodium current.Potassium channel activators differentially modulate the effect of sodium channel blockade on cardiac conduction.A case of near-fatal flecainide overdose in a neonate successfully treated with sodium bicarbonate.Pharmacological conversion of recent-onset atrial fibrillation: a systematic review.Brugada syndrome ECG pattern and fever: too warm is bad.Oral flecainide is effective in management of refractory tachycardia in infants.Brugada ECG Pattern Unmasked by IV Flecainide in an Individual with Idiopathic Fascicular Ventricular Tachycardia.Polymorphism and solvates of flecainide base.Comparison of the intrinsic vasorelaxant and inotropic effects of the antiarrhythmic agents vernakalant and flecainide in human isolated vascular and cardiac tissues.Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation.Hypertonic sodium bicarbonate versus intravenous lipid emulsion in a rabbit model of intravenous flecainide toxicity: no difference, no sink.SCN5A promoter haplotype affects the therapeutic range for serum flecainide concentration in Asian patients.Wolff-Parkinson-White, Brugada phenocopy, and flecainide toxicity: All in one patientA novel method of fetal cardioversionA life-threatening flecainide overdose treated with intravenous fat emulsionElectrophysiological and hemodynamic effects of vernakalant and flecainide during cardiac resynchronization in dyssynchronous canine heartsArrhythmogenic effect of flecainide toxicity
P921
Q10354103-FE36040E-BD0C-4D5E-B862-BE5E4787502DQ118551-ADE85710-98C6-4176-82E1-FC931EF761E3Q144085-7B254210-0E21-4ED9-B542-BE65053EDD8AQ165399-3DDA2042-CBD6-44B1-B303-896ADF662C70Q174259-DC9389BE-8030-456B-B812-B0BD8C500D4FQ179996-1FA348E7-E669-4A58-9AD3-491CA1C47220Q213511-D08A59BF-0861-47A7-95D9-1E5973E3B36BQ251347-23E78C97-215E-41B7-82A8-27EDE9C7F073Q3712521-7CFD345D-A913-4D1D-AD14-CC2E2BA323BFQ3791612-6E653D55-8252-40A5-AA17-B961BEF4377EQ407972-64664157-E0E7-45F6-9BEF-C382B7C9A37CQ408163-DDFCB7E8-D5DC-4645-AA2E-811C576BA14AQ408637-41A43EAB-AB6B-4DBE-B5D8-A7C0C3831629Q409672-572F6AEE-D15E-4C92-A727-30AA83D5679FQ410011-2DDAA2B2-83F7-4AF3-9F90-BDC8E2CCACCAQ410061-0A9DB1E0-ACF9-47C4-88CB-99953BE565BBQ412496-D06C02F1-99DF-4CA7-BEE5-90A11476781CQ413591-740C8B3F-DF64-4747-881F-5DCE70EA3409Q41576-0CD09F33-8201-4FEC-BC37-16CA045860DAQ416206-E102778F-9B16-478A-B84F-0E1C00655B9BQ417597-E853937C-92C2-45BF-8ACD-7541CB547D39Q417909-76E872E3-15D6-47E1-8F5C-C5A340206967Q419394-FBF5521D-AA8E-4BBC-8013-264721BC930BQ422418-4579AD26-7FC9-403A-890C-FA00349E47D0Q422438-EAC87E11-D836-40B4-B0E6-9A4D906CB59DQ423437-37A9141C-9F4B-46F0-A1CF-3F0ACC913536Q423757-FC612D07-FB23-46AA-AB42-B15639E2C5E2Q424238-99BEC88B-86D9-4763-8DE3-A5B7CC1A18A1Q424940-FB5EC7F3-B7CE-48C3-A053-A51C1C013438Q425120-E5BE300C-00B6-4860-8342-B83154BBAF46Q425295-FB450093-2F47-49E1-BA4B-F8B7E75B9DB6Q4890934-23E0F96C-FE0B-4072-A4FD-814302C4520BQ58375-B53F55B0-F377-40FF-8BE9-DAF0082D1424Q6821618-E3D8D26D-727A-43F4-8261-D616A01BF274Q7739-4727F87C-7404-46A9-A923-CFF0B6588A7CQ947595-87BB851A-9716-433D-80D6-2C547F2721BBQ976559-14E5AF3E-6A04-41E3-A7AC-A971F97D57D3
P769
description
antiaritmico di classe IC
@it
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Flecainid
@de
Flecainida
@es
Flecainide
@it
Flecainide
@nl
Flecainide
@vi
Flekainid
@sh
flecainida
@pt
flecainide acetate 100 mg tab
@ro
flecainide
@en
fleccainide
@ko
type
label
Flecainid
@de
Flecainida
@es
Flecainide
@it
Flecainide
@nl
Flecainide
@vi
Flekainid
@sh
flecainida
@pt
flecainide acetate 100 mg tab
@ro
flecainide
@en
fleccainide
@ko
altLabel
(+-)-Flecainide
@en
(+-)-flecainide
@en
54143-55-4
@fr
Almarytm
@it
C17H20F6N2O3
@it
CCRIS 313
@en
Flecaine
@en
Flecainida
@en
Flecainide
@en
Flecainidum
@en
prefLabel
Flecainid
@de
Flecainida
@es
Flecainide
@it
Flecainide
@nl
Flecainide
@vi
Flekainid
@sh
flecainida
@pt
flecainide acetate 100 mg tab
@ro
flecainide
@en
fleccainide
@ko